[Septal alcoholisation of hypertrophic obstructive cardiomyopathy in childhood]

S Abbey1, P Guérin, V Gournay

  • 1Clinique de cardiologie, CHU de Nantes, hôpital Guillaume et René Laennec, Nantes.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|June 22, 2005
PubMed

Insights

Septal alcoholization offered temporary relief for a child with hypertrophic obstructive cardiomyopathy and heart failure. This interventional cardiology procedure may be an alternative when surgery is not feasible.

Area of Science:

  • Interventional Cardiology
  • Pediatric Cardiology
  • Cardiac Surgery

Background:

  • Hypertrophic obstructive cardiomyopathy (HOCM) in children can lead to severe congestive cardiac failure.
  • Optimal medical management with beta-blockers may be insufficient in some pediatric HOCM cases.
  • Co-existing conditions like cystic fibrosis with resistant infections can complicate treatment decisions.

Observation:

  • A 6-year-old child with HOCM and congestive cardiac failure, despite beta-blocker therapy, underwent septal alcoholization.
  • The procedure, adapted from adult techniques, successfully reduced the pressure gradient and improved heart failure symptoms initially.
  • Recurrence of right heart failure and gradient increase after 10 months necessitated surgical myectomy.

Findings:

  • Septal alcoholization provided immediate hemodynamic improvement in a pediatric HOCM patient.
  • The effect of septal alcoholization was not durable, with symptom recurrence observed at 10 months.
  • Surgical myectomy was ultimately required, despite initial procedural success.

Implications:

  • Septal alcoholization represents a potential therapeutic option for pediatric HOCM, particularly when conventional surgery is contraindicated.
  • This case highlights the need for long-term monitoring after septal alcoholization in children.
  • Further research is warranted to evaluate the long-term efficacy and safety of septal alcoholization in pediatric HOCM.

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...